JP Morgan Chase
XGN icon

JP Morgan Chase’s Exagen XGN Stock Holding History

JP Morgan Chase’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608 Buy
128
+123
+2,460% +$463 ﹤0.01% 7394
2026
Q1 		$13 Sell
5
-3,900
-100% -$15.1K ﹤0.01% 7420
2025
Q4 		$23.7K Sell
3,905
-12,114
-76% -$110K ﹤0.01% 6462
2025
Q3 		$176K Buy
16,019
+16,014
+320,280% +$142K ﹤0.01% 5583
2025
Q2 		$35 Hold
5
– – ﹤0.01% 6922
2025
Q1 		$18 Hold
5
– – ﹤0.01% 7142
2024
Q4 		$21 Sell
5
-30
-86% -$108 ﹤0.01% 7266
2024
Q3 		$108 Hold
35
– – ﹤0.01% 6990
2024
Q2 		$64 Buy
35
+1
+3% +$2 ﹤0.01% 6976
2024
Q1 		$54 Buy
34
+9
+36% +$17 ﹤0.01% 7020
2023
Q4 		$50 Sell
25
-2,252
-99% -$3.9K ﹤0.01% 7207
2023
Q3 		$5.58K Buy
2,277
+14
+0.6% +$35 ﹤0.01% 6363
2023
Q2 		$6.56K Hold
2,263
– – ﹤0.01% 6121
2023
Q1 		$5K Sell
2,263
-79
-3% -$204 ﹤0.01% 6260
2022
Q4 		$6K Sell
2,342
-3,085
-57% -$7.91K ﹤0.01% 6138
2022
Q3 		$15K Sell
5,427
-2,449
-31% -$13.7K ﹤0.01% 5882
2022
Q2 		$45K Sell
7,876
-1,023
-11% -$5.96K ﹤0.01% 5691
2022
Q1 		$72K Sell
8,899
-12,234
-58% -$105K ﹤0.01% 5647
2021
Q4 		$246K Buy
21,133
+5,597
+36% +$65.6K ﹤0.01% 5232
2021
Q3 		$211K Sell
15,536
-3,307
-18% -$44K ﹤0.01% 5201
2021
Q2 		$282K Buy
18,843
+4,547
+32% +$69.7K ﹤0.01% 5053
2021
Q1 		$250K Buy
14,296
+607
+4% +$10.8K ﹤0.01% 5060
2020
Q4 		$181K Buy
13,689
+8,857
+183% +$125K ﹤0.01% 4843
2020
Q3 		$54K Sell
4,832
-817
-14% -$10.5K ﹤0.01% 4916
2020
Q2 		$70K Sell
5,649
-2,708
-32% -$36.6K ﹤0.01% 4703
2020
Q1 		$133K Buy
8,357
+7,278
+675% +$144K ﹤0.01% 4433
2019
Q4 		$27K Buy
+1,079
New +$19.2K ﹤0.01% 5276

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

JP Morgan Chase's XGN Position: Q2 2026 in Review

JP Morgan Chase increased its Exagen (XGN) stake by 2,460% in Q2 2026, buying an estimated $463 and bringing the position to 128 shares worth $608. The position accounts for ﹤0.01% of the portfolio, ranked #7394.

JP Morgan Chase first reported a position in XGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $282K in Q2 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • JP Morgan Chase held 128 shares of Exagen worth $608 as of Q2 2026.
  • JP Morgan Chase bought 123 Exagen shares in Q2 2026, an estimated $463.
  • Exagen made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7394 holding.
  • JP Morgan Chase first reported a position in Exagen in Q4 2019 and has held it in 27 quarters since.
  • JP Morgan Chase's Exagen position peaked at $282K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.